Drug intelligence / Profile preview

Satisfem Gel

Development stage: Unknown
Lead developer: FemmePharma
Administration: Topical, Intravaginal

Overview

Satisfem Gel is a **non-hormonal vulvar and vaginal moisturizing gel** developed by FemmePharma for the self-care management of menopausal vulvovaginal dryness and related symptoms such as itching, burning, and irritation. It is marketed over the counter as a **pharmaceutical-grade topical moisturizer** and is better characterized as a **medical device or personal care product** than as a targeted pharmaceutical drug. Its activity appears to derive from local hydration, lubrication, and barrier-support effects from ingredients such as hyaluronic acid, vitamin E, glycerin, and other moisturizing excipients rather than from a defined receptor-mediated biological mechanism.

Brand names: Satisfem Gel
Other names: Satisfem

Beyond the preview

Go deeper on Satisfem Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Satisfem Gel.

Explore the full profile